
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsDiverse Academic Research Areas · Psychological Testing and Assessment · Gender and Technology in Education
Fully remote intensive trauma-focused treatment for PTSD and Complex PTSD
H. Bongaerts, Voorendonk, E. M., Van Minnen, A., Rozendaal, L., Telkamp, B. S. D., & de Jongh, A. (2022).
Journal of Psychotraumatology, 13(2), 2103287
https://doi.org/10.1080/20008066.2022.2103287
During preparation for another study, coding errors were discovered. These errors involved mistakenly coding some female participants as male. Further investigation showed that this coding error also affected some of the data used in this study. Several women were coded as male, which changed the outcomes of the study somewhat for the analyses in which gender was examined. Therefore, we have corrected the contents of the article. All corrections involve (only) the Results section:
- The mean age of this group of participants was 37.16 years (SD = 11.82, age range 19–63), and 37 (50.7%) were female.
Now reads:
The mean age of this group of participants was 37.16 years (SD = 11.82, age range 19–63), and 62 (85%) were female.
- Table 1 has been revised.
Now reads:
Table 1.Descriptives of the total sample of patients at baseline: Mean scores of the Clinician Administered PTSD Scale for DSM-5 (CAPS-5), PTSD Checklist for DSM-5 (PCL-5), and International Trauma Questionnaire (ITQ), age and sex, PTSD and Complex PTSD diagnosis, traumatic events according to the Life Events Checklist for DSM-5 (LEC-5), comorbidity, suicidal ideation. Total SampleVariable n MSDMin.Max.CAPS-5 pre-treatment7338.717.032456CAPS-5 post-treatment7313.1211.70044CAPS-5 follow-up 05715.6314.70055PCL-5 pre-treatment7345.5112.091670PCL-5 post-treatment6119.0216.52070PCL-5 follow-up6221.8118.40067ITQ-DSO pre-treatment7013.075.34322ITQ-DSO post-treatment606.456.08020ITQ-DSO follow-up637.296.60021Age7337.1611.821963 Sex1
** n **
% Male1115 PTSD at pre-treatment in accordance with CAPS-51
** n **
% Patients with PTSD73100 CPTSD at pre-treatment in accordance with ITQ2
** n **
% Patients with Complex PTSD3347,1 LEC-51
** n **
% Physical abuse6487.7 Sexual abuse4865.8 Other traumatic events4460.3 Life threatening situations such as accidents3750.7 Natural disasters68.2 Warzone situations56.8 One or more Comorbidity1
** n **
% Depressive disorders3953.4 Anxiety disorders4054.8 Suicidal ideation1n% Reported moderate to high suicidal risk1926.0 Note. ^1^ n = 73. ^2^ n = 70.
3.2. CAPS-5
The addition of predictors and covariates to the random intercept model improved the fit significantly, (Δχ²[6] = 189.25, p < .001). Adding a random slope for ‘measurement time point’ improved the fit of the model again (Δχ²[5] = 53.57, p < .001), which led to our main models 1 and 2 (see Table 3). The intercept for Model 1 (b0 = 35.62, SE = 1.51) represents the estimated mean value for the reference group at pre-treatment (reference group is ‘woman of average age, without Complex PTSD at pre-treatment and no missing data for the three instruments).
Now reads:
The addition of predictors and covariates to the random intercept model improved the fit significantly, (Δχ²[6] = 189.59, p < .001). Adding a random slope for ‘measurement time point’ improved the fit of the model again (Δχ²[5] = 53.37, p < .001), which led to our main models 1 and 2 (see Table 3). The intercept for Model 1 (b0 = 35.79, SE = 1.41) represents the estimated mean value for the reference group at pre-treatment (reference group is ‘woman of average age, without Complex PTSD at pre-treatment and no missing data for the three instruments).
Table 2 has been revised:
Table 2.Multilevel regression analyses of the Clinician Administered PTSD Scale for DSM-V (CAPS-5) by measurement moment, age and sex, and Complex PTSD.Dependent variable: CAPS-5 Model 1Model 2PredictorbSE p bSE p Level 1 Pre-treatment (intercept)35.781.41.0035.581.44.00Post-treatment-25.811.43.00-24.841.97.00Six months follow up-23.151.76.00-22.622.45.00Level 2Male1.272.27.581.282.28.58Age0.060.07.380.060.07.38Complex PTSD4.991.69.0045.431.79.004Participants with missing data0.711.68.680.711.69.68Interaction effectPost * Complex PTSD -2.072.86.47Follow-up * Complex PTSD -1.163.54.74 Variances (random effects)Pre-treatment (intercept)30.6930.67Post treatment112.75111.73Six months follow up162.16161.20Residual12.3912.36Level I: number of observations195195Level 2: number of participants7070 Compared to random intercept, random slopes modelCompared to Model 1Log likelihood ratio test Delta X^2^ (df)53.37 (5)0.62 (2) p .001.74ICC (random intercept only model)0.00 Note 1: Reference group (Intercept); Female, average Age, Completed all measurements, No Complex PTSD, at Pre-Treatment.Note 2: Random Intercept and Random Slope For Measurement Moment for Models 1 and 2.
Table 3 has been revised:
Table 3.Multilevel regression analyses of the PTSD Checklist for DSM-5 (PCL-5) by measurement moment, age and sex, and Complex PTSD.Dependent variable: PCL-5 Model 1Model 2PredictorbSE p bSE p Level 1 Pre-treatment (intercept)38.192.83.0037.012.17.00Post-treatment-26.191.92.00-22.652.76.00Six months follow up-23.021.92.00-21.622.79.00Level 2 Male3.864.40.382.923.54.41Age0.160.13.24-0.0060.11.096Complex PTSD11.033.21.00113.012.68.00Participants with missing data2.893.25.0383.992.61.13Interaction effect Post * Complex PTSD -7.514.02.06Follow-up * Complex PTSD -3.144.15.45 Variances (random effects)Pre-treatment (intercept)73.4873.65Post treatment218.88201.27Six months follow up216.75214.89Residual21.5121.05Level I: number of observations190190Level 2: number of participants7070 Compared to random intercept, random slopes modelCompared to Model 1Log likelihood ratio test Delta X^2^ (df)37.494.09 p <.001.13ICC (random intercept only model)0.131 Note 1: Reference group (Intercept); Female, average Age, Completed all measurements, No Complex PTSD, at Pre-Treatment.Note 2: Random Intercept and Random Slope For Measurement Moment for Models 1 and 2.
